TheProfitWatch

AXSM - Axsome Therapeutics, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
143.9 4.89 (3.4%) 0.04 (0.03%) 0.2 (0.13%) 0.49 (0.33%) --- 4.89 (3.4%) 0.0 (0.0%) 0.0 (0.0%)

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.97
Diluted EPS:
-0.97
Basic P/E:
-153.3918
Diluted P/E:
-153.3918
RSI(14) 1m:
60.54
VWAP:
148.75
RVol:

Events

Period Kind Movement Occurred At

Related News